AlphaVax, Inc. Announces Nomination for 2012 Vaccine Industry Excellence Award
3/21/2012 9:43:44 AM
More...
|
AlphaVax, Inc. Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
7/19/2009 10:49:26 PM
More...
|
AlphaVax, Inc. Announces Full Enrollment in Phase I/II Study of Active Immunotherapy in Patients with Advanced or Metastatic Cancer
5/14/2009 9:44:56 AM
More...
|
AlphaVax, Inc. Announces Promising Results in Melanoma Studies
5/13/2009 9:21:10 AM
More...
|
Novartis AG (JOBS) Licenses Vaccine Candidates from US Group, AlphaVax, Inc. for $20 Million
12/29/2008 7:55:11 AM
More...
|
AlphaVax, Inc. Receives Conditional Approval to List on the TSX Venture Exchange
8/13/2008 10:46:52 AM
More...
|
AlphaVax, Inc. Announces Initiation of Chlamydia Vaccine Program
7/21/2008 10:27:40 AM
More...
|
AlphaVax, Inc. Continues to Expand the Use of Its Vaccine Platform
6/6/2008 11:15:00 AM
More...
|
AlphaVax, Inc. Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
4/17/2008 7:55:51 AM
More...
|
AlphaVax, Inc. Announces New CMV Advisory Board
1/30/2008 10:00:07 AM
More...
|
|